ELISA Kit:

Description	Cat. No	Sample	Specification
HAV IgG	814091	Serum/Plasma	96T
HAV IgM	814092	Serum/Plasma	96T
HBsAg	812090	Serum/Plasma	96T
HBsAb	812291	Serum/Plasma	96T
HBeAg	814190	Serum/Plasma	96T
HBeAb	814191	Serum/Plasma	96T
HBcAb IgG	814291	Serum/Plasma	96T
HBcAb IgM	814292	Serum/Plasma	96T
HCV IgG	812391	Serum/Plasma	96T
HCV IgM	812392	Serum/Plasma	96T
HDV IgG	814391	Serum/Plasma	96T
HDV IgM	814392	Serum/Plasma	96T
HDV Ag	814390	Serum/Plasma	96T
HEV IgG	814491	Serum/Plasma	96T
HEV IgM	814492	Serum/Plasma	96T
HGV IgG	814591	Serum/Plasma	96T
HGV IgM	814592	Serum/Plasma	96T
HIV IgG	812491	Serum/Plasma	96T
HIV IgM	812492	Serum/Plasma	96T
H.P.IgG (Quantitative)	812691	Serum/Plasma	96T
AFP	817190	Serum/Plasma	96T
CEA	817290	Serum/Plasma	96T
PSA	817390	Serum/Plasma	96T
f-PSA	817490	Serum/Plasma	96T
Ferittin	817590	Serum/Plasma	96T
CA125	817690	Serum/Plasma	96T
CA15-3 A	817790	Serum/Plasma	96T
CA19-9	817890	Serum/Plasma	96T
hCG	811090	Serum/Plasma	96T
LH	811290	Serum/Plasma	96T
FSH	811390	Serum/Plasma	96T
T3	811490	Serum/Plasma	96T
T4	811590	Serum/Plasma	96T
TSH	811690	Serum/Plasma	96T
CMV IgG	816191	Serum/Plasma	96T
CMV IgM	816192	Serum/Plasma	96T
HSV-1 IgG	816291	Serum/Plasma	96T
HSV-1 IgM	816292	Serum/Plasma	96T
HSV-2 IgG	816391	Serum/Plasma	96T
HSV-2 IgM	816392	Serum/Plasma	96T
Rub IgG	816491	Serum/Plasma	96T
Rub IgM	816492	Serum/Plasma	96T
Toxo IgG	816591	Serum/Plasma	96T
Toxo IgM	816592	Serum/Plasma	96T

Shanghai Biochip Co., Ltd.（SBC） was founded in Aug. 2001. The existing shareholders of the company include some well-known universities, research institutes, hospitals and enterprises in China. In Feb. 2003, the National Development and Reform Commission authorized SBC to build up and operate the National Engineering Center for biochip at Shanghai project. The company is located in the Zhangjiang High-tech Park Biotech&Pharmaceutical Industrial Base in Pudong Shanghai with a total area of 40,000 square meters, a construction area of over 20,000 square meters, and a current employee number of more than 300 people.

In accordance with company's development strategy and the construction requirements raised by National Development and Reform Commission for the National Engineering Center, SBC is committed to applying and promoting biotechnology development and products for life science research、health-care、 drug discovery and other fields. Through more than 10 years of construction and development, the technology innovation service system is established which is based on the core platforms of the biological sample bank, tissue chips, gene expression chips and the next-generation sequencing; The industrialized system which takes molecular medical diagnosis technology and product development as the core competitiveness has been set up; And three main business areas which include the services for research and drugs R&D, molecular medicine inspection services, and production and sales of molecular diagnostic product.

SBC obeys the value idea of “Scientific innovation, Business orientation, Career development”, follows the construction requirements for the National Engineering Center, and strives to make the company an internationally-advanced national bio-chip industrialization base which integrates the function of technology innovation, achievements transformation, comprehensive service and personal training as a whole. What’s more, the company’s strategic goal is to be an innovative benchmark enterprise among the industry with an level internationally-advanced and has the capability of independent research and development. It would make a contribution to the goal of making Shanghai an influential technology innovation center and also contribute to the domestic field of biomedical science and technology innovation and industrialization in our country.